Validation of LymphGen classification on a 400-gene clinical next-generation sequencing panel in diffuse large B-cell lymphoma: Real-world experience from a cancer center Research Letter


Authors: Zhu, M. L.; Drill, E.; Joffe, E.; Salles, G.; Rivas Delgado, A.; Zelenetz, A.; Palomba, M. L.; Arcila, M.; Dogan, A.
Title: Validation of LymphGen classification on a 400-gene clinical next-generation sequencing panel in diffuse large B-cell lymphoma: Real-world experience from a cancer center
Keywords: immunohistochemistry; adult; aged; middle aged; single nucleotide polymorphism; exon; genetics; sensitivity and specificity; letter; clinical practice; gene expression; cytogenetics; tumor marker; tumor suppressor gene; b cell lymphoma; germinal center; algorithm; diagnosis; lymphoma, large b-cell, diffuse; lymphoid enhancer factor 1; copy number variation; procedures; diffuse large b cell lymphoma; high throughput sequencing; high-throughput nucleotide sequencing; humans; human; male; female; whole exome sequencing; biomarkers, tumor
Journal Title: Haematologica
Volume: 109
Issue: 7
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2024-07-01
Start Page: 2326
End Page: 2330
Language: English
DOI: 10.3324/haematol.2023.284565
PUBMED: 38497151
PROVIDER: scopus
PMCID: PMC11215372
DOI/URL:
Notes: Letter -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Menglei Zhu (Listed as 'Meng-Lei' on the original publication) -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba
  2. Andrew D Zelenetz
    767 Zelenetz
  3. Maria Eugenia Arcila
    657 Arcila
  4. Esther Naomi Drill
    93 Drill
  5. Ahmet Dogan
    454 Dogan
  6. Erel Joffe
    82 Joffe
  7. Menglei Zhu
    35 Zhu
  8. Gilles Andre Salles
    269 Salles